Ultralife (NASDAQ:ULBI) Downgraded by StockNews.com to Buy

StockNews.com lowered shares of Ultralife (NASDAQ:ULBI) from a strong-buy rating to a buy rating in a research report released on Thursday morning.

Separately, Benchmark increased their target price on shares of Ultralife from $12.00 to $13.00 and gave the company a buy rating in a research report on Tuesday, March 5th.

Ultralife Stock Down 0.1 %

Shares of NASDAQ:ULBI opened at $12.55 on Thursday. Ultralife has a fifty-two week low of $3.92 and a fifty-two week high of $12.68. The firm’s 50 day moving average price is $9.49 and its 200 day moving average price is $8.23. The company has a quick ratio of 2.16, a current ratio of 4.03 and a debt-to-equity ratio of 0.18. The stock has a market cap of $206.70 million, a price-to-earnings ratio of 19.61 and a beta of 1.12.

Ultralife (NASDAQ:ULBI) last posted its earnings results on Thursday, February 15th. The technology company reported $0.18 EPS for the quarter. The firm had revenue of $44.55 million for the quarter. Ultralife had a return on equity of 10.31% and a net margin of 6.19%.

Hedge Funds Weigh In On Ultralife

A number of institutional investors have recently modified their holdings of ULBI. Janney Montgomery Scott LLC increased its position in Ultralife by 10.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock valued at $3,868,000 after acquiring an additional 40,000 shares during the period. Visionary Wealth Advisors grew its stake in shares of Ultralife by 0.9% in the 4th quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock valued at $7,381,000 after purchasing an additional 9,997 shares during the last quarter. D.A. Davidson & CO. acquired a new position in shares of Ultralife in the fourth quarter valued at approximately $163,000. Navellier & Associates Inc. purchased a new stake in shares of Ultralife during the fourth quarter worth approximately $310,000. Finally, Victory Capital Management Inc. acquired a new stake in shares of Ultralife during the fourth quarter worth $59,000. 30.68% of the stock is owned by institutional investors and hedge funds.

About Ultralife

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.